Loading clinical trials...

RNF213 Variants and Collateral Vessels in Moyamoya Disease | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDNCT04906564

RNF213 Variants and Collateral Vessels in Moyamoya Disease

The purpose of this study is to detect the association between RNF213 variants and collateral vessels in patients with moyamoya disease.

Lead sponsor: Beijing Tiantan Hospital•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Start Free Trial

Sponsors

Lead Sponsor

Beijing Tiantan Hospital

Related studies

Cognitive-Motor Incorporated Training and Its Relations in Cerebrovascular Diseases With Cognitive and Motor Impairments

NCT07144930 · Moyamoya Disease, Healthy, and more

RECRUITINGPhase 1

Treatment of Moyamoya Disease With iPSC-derived Exosomes

NCT07065409 · Moyamoya Disease

Neurosurgical Outcome Network

NCT06724029 · Aneurysms, Arteriovenous Malformations, and more

Long-term Outcomes of Conservative Management in Patients with Moyamoya Disease and Their First-degree Relatives (LAMORA)

NCT05332756 · Moyamoya Disease

Enrolling By InvitationNA

A Study of Cerebral Perfusion With tDCS in Chronic Hypoperfusion

NCT06477107 · Moyamoya Syndrome, Moyamoya Disease, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: February 17, 2022Terms

Trial snapshot

StatusCOMPLETED

Phase—

Enrollment300

Start dateJan 2019

Last updatedFeb 17, 2022

Condition

Moyamoya Disease

Locations shown

Beijing Tiantan Hospital Capital Medical University

Beijing, Beijing Municipality

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: February 17, 2022Data synced to Clareo: May 10, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions